Disruption of elastic lamellae in aorta and dysfunction of vaso-regulation by rofecoxib in rats
-
Published:2013
Issue:5
Volume:38
Page:719-729
-
ISSN:0388-1350
-
Container-title:The Journal of Toxicological Sciences
-
language:en
-
Short-container-title:J. Toxicol. Sci.
Author:
Miyajima Atsushi1, Okamoto Masahiro1, Muto Takafumi1, Hirota Takashi1
Affiliation:
1. Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science
Publisher
Japanese Society of Toxicology
Reference36 articles.
1. Aldington, S., Shirtcliffe, P., Weatherall, M. and Beasley, R. (2005): Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy. N Z Med. J., 118, U1684. 2. Belz G.G. (1995): Elastic properties and Windkessel function of the human aorta. Cardiovasc. Drugs Ther., 9, 73-83. 3. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M.B., Hawkey, C.J., Hochberg, M.C., Kvien, T.K. and Schnitzer, T.J. (2000): Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N. Engl. J. Med., 343, 1520-1528. 4. Bresalier, R.S., Sandler, R.S., Quan, H., Bolognese, J.A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., Konstam, M.A. and Baron, J.A. (2005): Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med., 352, 1092-1102. 5. Carta, L., Pereira, L., Arteaga-Solis, E., Lee-Arteaga, S.Y., Lenart, B., Starcher, B., Merkel, C.A., Sukoyan, M., Kerkis, A., Hazeki, N., Keene, D.R., Sakai, L.Y. and Ramirez, F. (2006): Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J. Biol. Chem., 281, 8016-8023.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|